PL379457A1 - Kompozycje do profilaktyki i leczenia objawów przeziębienia i grypy, zawierające wybrane polimery mukoadhezyjne - Google Patents

Kompozycje do profilaktyki i leczenia objawów przeziębienia i grypy, zawierające wybrane polimery mukoadhezyjne

Info

Publication number
PL379457A1
PL379457A1 PL379457A PL37945703A PL379457A1 PL 379457 A1 PL379457 A1 PL 379457A1 PL 379457 A PL379457 A PL 379457A PL 37945703 A PL37945703 A PL 37945703A PL 379457 A1 PL379457 A1 PL 379457A1
Authority
PL
Poland
Prior art keywords
compositions
influenza
cold
treatment
prevention
Prior art date
Application number
PL379457A
Other languages
English (en)
Inventor
Jayant Ekanth Khanolkar
La Harpe Shane Michael De
Benoit Maurice Mullet
Paul John Rennie
Philip David Williams
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of PL379457A1 publication Critical patent/PL379457A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
PL379457A 2003-01-13 2003-12-23 Kompozycje do profilaktyki i leczenia objawów przeziębienia i grypy, zawierające wybrane polimery mukoadhezyjne PL379457A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34115603A 2003-01-13 2003-01-13

Publications (1)

Publication Number Publication Date
PL379457A1 true PL379457A1 (pl) 2006-09-18

Family

ID=32770191

Family Applications (1)

Application Number Title Priority Date Filing Date
PL379457A PL379457A1 (pl) 2003-01-13 2003-12-23 Kompozycje do profilaktyki i leczenia objawów przeziębienia i grypy, zawierające wybrane polimery mukoadhezyjne

Country Status (12)

Country Link
EP (1) EP1583559B1 (pl)
JP (1) JP2006514077A (pl)
CN (1) CN1735434A (pl)
AT (1) ATE463257T1 (pl)
AU (1) AU2003302332A1 (pl)
CA (1) CA2509775C (pl)
DE (1) DE60332044D1 (pl)
ES (1) ES2342935T3 (pl)
MX (1) MXPA05007491A (pl)
PL (1) PL379457A1 (pl)
RU (1) RU2339403C2 (pl)
WO (1) WO2004064867A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
JP2006104114A (ja) * 2004-10-04 2006-04-20 Rohto Pharmaceut Co Ltd 粘膜適用組成物
US20070110676A1 (en) * 2005-11-17 2007-05-17 The Procter & Gamble Company Compositions useful for prevention and treatment of common cold and influenza-like symptoms
GB0602325D0 (en) * 2006-02-06 2006-03-15 Remedy Res Ltd Virucidal compositions and uses
BRPI0710654B1 (pt) 2006-04-21 2021-11-03 Toko Yakuhin Kogyo Kabushiki Kaisha Preparação de adesivo para pele/mucosa do tipo gel, pulverizável, e sistema de administração usando a preparação
EP2217279B1 (en) 2007-11-21 2017-11-01 The Procter & Gamble Company Preparations useful for treatment of cough
IT1400721B1 (it) * 2010-07-07 2013-06-28 Baldacci Lab Spa Composizioni a base di acido pirrolidoncarbossilico (pca) e sali metallici.
CN103284954A (zh) * 2013-06-28 2013-09-11 辽宁亿灵科创生物医药科技有限公司 惰性纤维素鼻喷剂
JP6465820B2 (ja) * 2016-01-15 2019-02-06 安井 敦司 抗菌・抗ウイルス性組成物およびこれを含む潤滑剤
EP3950338A4 (en) 2019-03-29 2022-05-04 Mitsubishi Chemical Corporation RESIN COMPOSITION, FILM AND MULTI-LAYER STRUCTURE
JP7771511B2 (ja) * 2019-10-30 2025-11-18 三菱ケミカル株式会社 樹脂組成物、フィルム及び多層構造体
JP7748103B2 (ja) * 2020-03-30 2025-10-02 住化エンバイロメンタルサイエンス株式会社 抗ウイルス剤
WO2021211085A1 (ru) * 2020-04-17 2021-10-21 Кумар ГУНЬЯН Способ профилактики и лечения заболеваний, вызванных вирусами, имеющими оболочку, в том числе коронавирусами(варианты) и набор фармацевтических препаратов для его осуществления
US20220133786A1 (en) * 2020-05-01 2022-05-05 Tygrus, LLC THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES
CN111759851B (zh) * 2020-08-17 2021-01-26 广东盛普生命科技有限公司 单宁酸在制备抗冠状病毒的药物方面的应用
WO2022061004A1 (en) * 2020-09-16 2022-03-24 Accelerated Woundcare Research, Inc. Nasal spray compositions to suppress coronavirus and other pathogens and methods of use
WO2022061010A1 (en) * 2020-09-16 2022-03-24 Accelerated Woundcare Research, Inc. Antiviral oral composition, method of making the oral composition and oral hygiene method
CN117482279A (zh) * 2023-06-20 2024-02-02 湖南易天然医疗科技有限公司 一种雾化液体敷料及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158761A (en) * 1989-04-05 1992-10-27 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5989535A (en) * 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
CA2382985A1 (en) * 1999-10-19 2001-04-26 Jeffrey Michael Morgan Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts
US7101576B2 (en) * 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations

Also Published As

Publication number Publication date
ATE463257T1 (de) 2010-04-15
MXPA05007491A (es) 2005-09-21
CA2509775C (en) 2010-06-01
AU2003302332A1 (en) 2004-08-13
CN1735434A (zh) 2006-02-15
ES2342935T3 (es) 2010-07-19
RU2339403C2 (ru) 2008-11-27
EP1583559B1 (en) 2010-04-07
CA2509775A1 (en) 2004-08-05
EP1583559A1 (en) 2005-10-12
JP2006514077A (ja) 2006-04-27
RU2005122729A (ru) 2006-01-27
DE60332044D1 (de) 2010-05-20
WO2004064867A1 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
MXPA05007491A (es) Composiciones para la prevencion y tratamiento de sintomas similares a la influenza y resfriado, que comrenden polimeros muco-adhesivos selectos.
CA2527365A1 (en) Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
WO2007123939A8 (en) Novel arylamino n-heteraryls as mek inhibitors
WO2006044775A3 (en) Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
WO2008070129A3 (en) Compositions and methods for the treatment of inflammatory disease
WO2004100881A3 (en) Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
WO2009064388A3 (en) Inhibitors of human methionine aminopeptidase 1 and methods of treating disorders
WO2007016538A3 (en) Preparation and use of biphenyl amino acid derivatives for the treatment of obesity
PT1981877E (pt) Compostos de n-hidroxiacrilamida
WO2009026179A3 (en) Antiinfective proanthocyanidin compounds and methods of use thereof
WO2007133865A3 (en) Hcv/hiv inhibitors an their uses
WO2009041787A3 (en) Pharmaceutical composition comprising inhibitors of cell adhesion molecule isolated from piper nigrum for the prevention and treatment of inflammatory disease
WO2009062990A3 (en) Equilibrative nucleoside transporter ent1 inhibitors
WO2006047415A3 (en) FACTOR Xa COMPOUNDS
WO2009130615A3 (de) Verwendung von deuteriumoxid als elastase-inhibitor
WO2009099405A3 (en) Antibacterial compositions and methods of treatment
WO2008072952A3 (en) Anti-inflammatory compounds containing compositions for treatment of cancer
WO2006108679A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use to combat cancer
WO2008053270A3 (en) Use of an egfr antagonist for the treatment of glomerolonephritis
WO2005110413A3 (en) Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
WO2007059356A3 (en) Furfurylidene- pyrazolidines and their use as inhibitors of ubiquitin e1
WO2011067608A8 (en) Treatment of allodynia and hyperalgesia
WO2009043523A3 (en) Cortistatin 17 and neuropeptide 1 for use as therapeutic agent
ATE486876T1 (de) N-sulfamoyl-n benzopyranpiperidine als hemmer von kohlenstoffanhydrasen
MXPA05006296A (es) Uso de tiazolobenzoheterociclos para el tratamiento de la esclerosis multiple.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)